Accurate Collection of Reasons for Treatment Discontinuation to Better Define Estimands in Clinical Trials.

Yongming QuRobin D WhiteStephen J Ruberg

Published in: Therapeutic innovation & regulatory science (2022)

Clinicaltrials.gov numbers: NCT01027871 (Phase 2 for type 2 diabetes), NCT01049412 (Phase 2 for type 1 diabetes), NCT01481779 (IMAGINE 1 Study), NCT01435616 (IMAGINE 2 Study), NCT01454284 (IMAGINE 3 Study), NCT01468987 (IMAGINE 4 Study), NCT01582451 (IMAGINE 5 Study), NCT01790438 (IMAGINE 6 Study), NCT01792284 (IMAGINE 7 Study).

Keyphrases

type diabetes
clinical trial
randomized controlled trial
adipose tissue
high resolution
metabolic syndrome
glycemic control
insulin resistance
study protocol
double blind
phase ii